KaloBios Pharmaceuticals Inc. : Franchise Herald

KaloBios Pharmaceuticals Inc.

KaloBios Pharmaceuticals Inc.

KaloBios to Acquire Benznidazole Program, Program is Used for the Treatment of Chagas Disease

KaloBios Pharmaceuticals, Inc. has announced in a press release that it will be acquiring a benznidazole program from Savant Neglected Diseases, LLC, a privately-held specialty pharmaceutical company. The program is used for the treatment of Chagas Disease.

Just In

Amazon CEO Andy Jassy Faces Backlash Over Tone-Deaf Comments Amidst New Seller Fees

Amazon mobile app

Target Enhances Family Safety with Car Seat Trade-In Event in Spring 2024

Baby looking through car window

Exclusive Sip: 7-Eleven Partners with Celebrity for New ZOA Energy Drink Flavor

7-Eleven

Cracker Barrel Confirms Permanent Shutdown of Beloved Restaurant Via Voice Message

Empty restaurant

JCPenney Unveils $500 Million Reward Scheme for Loyal Customers Nationwide

Mannequins

Most Read

1

Shop 'n Save Announces Closure Dates for All Locations, Aldi to Take Over Majority of Sites

Family shopping in the grocery

2

Fosters Freeze Closes All Locations Statewide, Citing New Wage Laws as a Contributing Factor

Man holding an ice cream

3

Sudden Closure: 'Walk On' Sports Bistreaux Announces Last-minute Shutdown, Sparking Employment Crisis

Closed Sign

4

Duck Donuts Closes One of Over 100 Locations, Leaves Heartfelt Facebook Note

Assorted color doughnuts

5

Target Faces Lawsuit in Illinois Over Alleged Secret Biometric Data Collection, Shoppers Could Receive $5K

Woman in the grocery